Health Economics and Outcomes Research (HEOR) Lead in Orphan and Nephrology - Zurich

Ort: Switzerland - Glattbrugg/Zurich

Funktion: Pricing and Market Access

Firma: Vifor Pharma

Brenda Nauli

International Talent Scout

+41 58 851 83 69

Richtlinien für Agenturen

Ihr Profil

Are you looking for a new challenge in a specialist pharmaceutical company?  An opportunity has arisen to join Vifor Pharma at our operational headquarters in Glattbrugg. The position of Health Economics and Outcomes Research (HEOR) Lead in Orphan and Nephrology will have the ability to develop & successfully implement the Orphan and Nephro HEOR Plan including: resourcing requirements, prioritization of evidence generation activities.
 
This HEOR Lead in Orphan and Nephrology role will have the following responsibilities: 
  • Comprehensive HEOR strategy for Orphan and Nephro Products (Avacopan & CCX140) in place, including PROs recommendation, Real-World Evidence, contribution to interventional Studies, etc)
  • In alignment with the Head of HEOR and the HEOR Lead Iron Deficiency consolidate and execute the HEOR plan across all disease areas and market archetypes
  • The HEOR strategy and plans are successfully integrated in the Access and Brand Plans and the HEOR role and expertise are fully embedded in the cross-functional team
Disease Area Focus

  • Lead the development of HEOR evidence that supports business strategies and Market Access efforts for Orphan and Nephro.
  • Develop and execute evidence generation activities (Clinical, Economic, PROs) leveraging Vifor’s Orphan and Nephro expertise, supporting Market Access strategies, engaging decision-makers, influencers, and stakeholders, in order to strengthen the brand value proposition and ensure patient access.
Geographic focus
  • Identify local evidence generation gaps, data sources and lead HEOR activities implementation across market archetypes
Communication & cooperation:
  • Develops an effective collaboration with the Orphan and Nephro GCT and especially with the Access Lead for Orphan and Nephro to design and execute strategies that demonstrate product value and support Market Access
  • Coordinates and collaborates with global, regional (if applicable) and country access and health economic experts (internal and external) to understand country-specific HEOR needs and opportunities and propose appropriate actions
Technical Expertise
  • Expands analytical contributions to Orphan and Nephro priorities, incorporating epidemiology, patient demographics and relevant macro aspects of healthcare systems and payer requirements
  • Proactively engages in defining potential health economics and outcomes research contributions to high impact commercialization activities, including segmentation, reimbursement, pricing, etc.
  • Advises Market Access, Medical Affairs, and Clinical colleagues in the design of health outcomes/interventional and observational trials in Orphan and Nephro with health economic and Patient Reported Outcomes (PRO) endpoints in alignment with therapy and product value propositions for optimal impact on access decision-makers, influencers, and stakeholders
  • Develops and/or keeps up-to-date health economic tools that are part of the Orphan and Nephro “core value tools” including BIM, CEM, GVD (AMCP & EUNetHTA format)
The knowledge and skills necessary to perform the duties of this position are typically acquired through the following combination of education, experience and knowledge, or the equivalent.

Minimum Requirements:
  • Undergraduate degree in Health or Social Sciences
  • PhD, MSc, or equivalent in Health Economics, Public Health, Health Policy, Epidemiology, Biostatistics, Mathematics or related field
  • 7 years of experience in health economics and/or outcomes research in pharmaceutical industry
  • Experience in one or more key markets and disease areas would be ideal (including top 5 European and/or the US, as well as Iron Deficiency)
  • Language requirement: English plus one other language ideally French, German, Spanish, Italian
We offer you an interesting and challenging opportunity in an international company. As a medium sized specialty Pharmaceutical company we work cross-functionally, with lean structures and an entrepreneurial mind-set. To achieve our goals we focus on solutions, effective processes and we constantly seek to improve our way of doing things. In response to our demanding environment we offer opportunities to bring forward ideas, lead change as well opportunities for personal development and growth. The company offers competitive terms and conditions.

Über uns

Die Vifor Pharma Gruppe – die frühere Galenica Gruppe – ist ein globales Spezialitäten-Pharmaunternehmen, das eigene Pharmaprodukte erforscht, entwickelt, herstellt und vertreibt und ein bevorzugter Partner für innovative patientenorientierte Lösungen ist. Das Unternehmen hat sich zum Ziel gesetzt, ein globaler Marktführer in den Bereichen Eisenmangel, Nephrologie und kardiorenale Therapien zu sein und weltweit Patienten mit schweren und chronischen Erkrankungen zu einem besseren Leben in Gesundheit zu verhelfen. Die Vifor Pharma Gruppe verfügt über Produktionsstätten in der Schweiz und in Portugal sowie über ein dynamisches Netzwerk von Vertriebsgesellschaften und Partnern zur weltweiten Marktabdeckung. Das Unternehmen treibt die Expansion seiner weltweiten Präsenz laufend voran, bleibt dabei aber in seinem schweizerischen Heimmarkt fest verwurzelt.

Die Vifor Pharma Gruppe besteht aus Vifor Pharma, Vifor Fresenius Medical Care Renal Pharma, ihrem gemeinsamen Unternehmen mit Fresenius Medical Care, Relypsa und OM Pharma.

Für mehr Informationen gehen Sie bitte auf: http://www.viforpharma.com/de/über-vifor-pharma/wer-wir-sind

Inhalt ein-/ausblenden

Bewerben
Teilen
LinkedIn Xing Send to a friend

Richtlinien für Agenturen